Virus safety of islet cell transplantation from transgenic pigs to marmosets

Virus Research

Volumn 204, Issue , 2015, Pages 95-102

  Plotzki, Elena ^a   Buerck, Lelia Wolf van ^b   Knauf, Yvonne ^c   Becker, Tamara ^c   Maetz Rensing, Kerstin ^c   Schuster, Marion ^b   Baehr, Andrea ^b   Klymiuk, Nikolai ^b   Wolf, Eckhard ^b   Seissler, Jochen ^b   Denner, Joachim ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c GERMAN PRIMATE CENTER   (Germany)

Author keywords

Porcine endogenous retroviruses; Porcine hepatitis E virus; Porcine herpes viruses; Virus safety; Xenotransplantation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALLITRICHINAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENDOGENOUS RETROVIRUS; FEMALE; HERPESVIRIDAE; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PORCINE ENDOGENOUS RETROVIRUS; PORCINE LYMPHOTROPIC HERPES VIRUS; PREVALENCE; PRIORITY JOURNAL; SAFETY; TRANSGENIC PIG; XENOTRANSPLANTATION; ADVERSE EFFECTS; ANIMAL; CALLITHRIX; DIABETES MELLITUS; HERPES VIRUS INFECTION; HUMAN; PANCREAS ISLET; PHYSIOLOGY; PIG; RETROVIRUS INFECTION; TRANSGENIC ANIMAL; TRANSMISSION; VIROLOGY;

ANIMALIA; HEPATITIS E VIRUS; HERPESVIRIDAE; PORCINE CYTOMEGALOVIRUS; PORCINE ENDOGENOUS RETROVIRUS; PRIMATES; SUIDAE; SUS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CALLITHRIX; DIABETES MELLITUS; ENDOGENOUS RETROVIRUSES; FEMALE; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; RETROVIRIDAE INFECTIONS; SAFETY; SWINE;

EID: 84930439482     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.04.016     Document Type: Article

References (54)

1. Abrahante J.E., Martins K., Papas K.K., Hering B.J., Schuurman H.-J., Murtaugh M.P. Microbiological safety of porcine islets: comparison with source pig. Xenotransplantation 2011, 18:88-93.
2. Adlhoch C., Wolf A., Meisel H., Kaiser M., Ellerbrok H., Pauli G. High HEV presence in four different wild boar populations in East and West Germany. Vet. Microbiol. 2009, 139(3-4):270-278.
3. American Diabetes Association. Type 1 Diabetes, 2015. http://www.diabetes.org/diabetes-basics/type-1/.
4. Busby S.A., Crossan C., Godwin J., Petersen B., Galli C., Cozzi E., Takeuchi Y., Scobie L. Suggestions for the diagnosis and elimination of hepatitis E virus in pigs used for xenotransplantation. Xenotransplantation 2013, 20(3):188-192.
5. Casu A., Bottino R., Balamurugan A.N., Hara H., van der Windt D.J., Campanile N., Smetanka C., Cooper D.K., Trucco M. Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008, 51(1):120-129.
6. Chmielewicz B., Goltz M., Franz T., Bauer C., Brema S., Ellerbrok H., Beckmann S., Rziha H.J., Lahrmann K.H., Romero C., Ehlers B. A novel porcine gammaherpesvirus. Virology 2003, 308(2):317-329.
7. Clark D.A., Fryer J.F., Tucker A.W., McArdle P.D., Hughes A.E., Emery V.C., Griffiths P.D. Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control. Xenotransplantation 2003, 10(2):142-148.
8. Cooper D.K., Bottino R., Satyananda V., Wijkstrom M., Trucco M. Toward clinical islet xenotransplantation-are revisions to the IXA guidelines warranted?. Xenotransplantation 2013, 20:68-74.
9. Costa M.R., Fischer N., Gulich B., Tönjes R.R. Comparison of porcine endogenous retroviruses infectious potential in supernatants of producer cells and in cocultures. Xenotransplantation 2014, (Epub ahead of print). 10.1111/xen.12081.
10. Denner J. Recombinant porcine endogenous retroviruses (PERV-A/C): a new risk for xenotransplantation?. Arch. Virol. 2008, 153(8):1421-1426. 2008.
11. Denner J. Porcine endogenous retrovirus infection of human peripheral blood mononuclear cells (PBMCs). Xenotransplantation 2014, (Epub ahead of print). 10.1111/xen.12150.
12. Denner J. Xenotransplantation and hepatitis E virus (HEV). Xenotransplantation 2015, (Epub ahead of print). 10.1111/xen.12156.
13. Denner J., Graham M. Xenotransplantation of islet cells: what can the non-human primate model bring for the evaluation of efficacy and safety?. Xenotransplantation 2015, 10.1111/xen.12169.
14. Denner J., Tönjens R.R. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin. Microbiol. Rev. 2012, 25:318-343.
15. Dieckhoff B., Kessler B., Jobst D., Kues W., Petersen B., Pfeifer A., Kurth R., Niemann H., Wolf E., Denner J. Distribution and expression of porcine endogenous retroviruses in multi-transgenic pigs generated for xenotransplantation. Xenotransplantation 2009, 16(2):64-73.
16. Dremsek P., Joe S., Baechlein C., Pavio N., Schielke A., Ziller M., Dürrwald R., Renner C., Groschup M.H., Johne R., Krumbholz A., Ulrich R.G. Hepatitis E virus seroprevalence of domestic pigs in Germany determined by a novel in-house and two reference ELISAs. J. Virol. Methods 2013, 190:11-16.
17. Dunn D.L., Mayoral J.L., Gillingham K.J., Loeffler C.M., Brayman K.L., Kramer M.A., Erice A., Balfour H.H.Jr., Fletcher C.V., Bolman R.M., Matas, Payn A.J., Sutherland W.D., Najaria D.E.R.J.S. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 1991, 51(1):98-106.
18. Fiebig U., Stephan O., Kurth R., Denner J. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?. Virology 2003, 307(2):406-413.
19. Fishman J.A., Scobie L., Takeuchi Y. Xenotransplantation-associated infectious risk: a WHO consultation. Xenotransplantation 2012, 19:72-78.
20. Garkavenko O., Dieckhoff B., Wynyard S., Denner J., Elliott R.B., Tan P.L., Croxson M.C. Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. J. Med. Virol. 2008, 80:2046-2052.
21. Goltz M., Widen F., Banks M., Belak S., Ehlers B. Characterization of the DNA polymerase loci of porcine cytomegaloviruses from diverse geographic origins. Virus Genes 2000, 21:249-255.
22. Graham M.L., Bellin M.D., Papas K.K., Hering B.J., Schuurman H.J. Species incompatibilities in the pig-to macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 2011, 18:328-342.
23. Graham M.L., Schuurman H.J. The usefulness and limitations of the diabetic macaque model in evaluating long-term porcine islet xenograft survival. Xenotransplantation 2013, 20:5-17.
24. International Diabetes Federation, 2014. http://www.idf.org/worlddiabetesday/toolkit/.
25. Irgang M., Sauer I.M., Karlas A., Zeilinger K., Gerlach J.C., Kurth R., Neuhaus P., Denner J. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J. Clin. Virol. 2003, 28:141-154.
26. Irgang M., Laue C., Velten F., Kurth R., Schrezenmeier J., Denner J. No evidence for PERV release by islet cells from German landrace pigs. Ann. Transplant. 2008, 13(4):59-66.
27. Jothikumar N., Cromeans T.L., Robertson B.H., Meng X.J., Hill V.R. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J. Virol. Methods 2006, 131:65-71.
28. Karlas A., Kurth R., Denner J. Inhibition of porcine endogenous retroviruses by RNA interference: increasing the safety of xenotransplantation. Virology 2004, 325(1):18-23. 2004.
29. Karlas A., Irgang M., Votteler J., Specke V., Ozel M., Kurth R., Denner J. Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/C. Ann. Transplant. 2010, 15(2):45-54.
30. Kaulitz D., Fiebig U., Eschricht M., Wurzbacher C., Kurth R., Denner J. Generation of neutralising antibodies against porcine endogenous retroviruses (PERVs). Virology 2011, 411(1):78-86.
31. Kaulitz D., Mihica D., Adlhoch C., Semaan M., Denner J. Improved pig donor screening including newly identified variants of porcine endogenous retrovirus-C (PERV-C). Arch. Virol. 2013, 158:341-348.
32. Kaulitz D., Mihica D., Dorna J., Costa M.R., Petersen B., Niemann H., Tönjes R.R., Denner J. Development of sensitive methods for detection of porcine endogenous retrovirus-C (PERV-C) in the genome of pigs. J. Virol. Methods 2011, 175:60-65.
33. Klymiuk N., van Buerck L., Bähr A., Offers M., Kessler B., Wuensch A., Kurome M., Thormann M., Lochner K., Nagashima H., Herbach N., Wanke R., Seissler J., Wolf E. Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes 2012, 61(6):1527-1532.
34. LaPorte R.E., Matsushima M., Chang Y.F. Prevalence and Incidence of Insulin-Dependent Diabetes, Diabetes in America 2013, 37-46. NIDDK, Available from: http://diabetes.niddk.nih.gov/dm/pubs/america/contents.aspx. 2nd ed.
35. Le Tissier P., Stoye J.P., Takeuchi Y., Patience C., Weiss R.A. Two sets of human-tropic pig retrovirus. Nature 1997, 389(6652):681-682.
36. Martin S.I., Wilkinson R., Fishman J.A. Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine. Virol. J. 2006, 3:91.
37. Mattiuzzo G., Takeuchi Y. Suboptimal porcine endogenous retrovirus infection in non-human primate cells: implication for preclinical xenotransplantation. PLoS ONE 2010, 5:e13203.
38. Morozov V.A., Morozov A.V., Rotem A., Barkai U., Bornstein S., Denner J. Extended microbiological characterization of Göttingen minipigs in the context of xenotransplantation: Detection and vertical transmission of hepatitis E virus. PLOS ONE 2015, (submitted).
39. Mueller K.R., Balamurugan A.N., Cline G.W., Pongratz R.L., Hooper R.L., Weegman B.P., Kitzmann J.P., Taylor M.J., Graham M.L., Schuurman H.J., Papas K.K. Differences in glucose-stimulated insulin secretion in vitro of islets from human, nonhuman primate, and porcine origin. Xenotransplantation 2013, 20:75-81.
40. Mueller N.J., Fishman J.A. Herpesvirus infections in xenotransplantation: pathogenesis and approaches. Xenotransplantation 2004, 11:486-490.
41. Mueller N.J., Takeuchi Y., Mattiuzzo G., Scobie L. Microbial safety in xenotransplantation. Curr. Opin. Organ Transplant. 2011, 16:201-206.
42. Ramanan P., Razonable R.R. Cytomegalovirus infections in solid organ transplantation: a review. Infect. Chemother. 2013, 45(3):260-271.
43. Ritzhaupt A., Van Der Laan L.J., Salomon D.R., Wilson C.A. Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell lines. J. Virol. 2002, 76:11312-11320.
44. Ramsoondar J., Vaught T., Ball S., Mendicino M., Monahan J., Jobst P., Vance A., Duncan J., Wells K., Ayares D. Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation 2009, 16(3):164-180.
45. Schleiss M.R. Developing a vaccine against congenital cytomegalovirus (CMV) infection: what have we learned from animal models? Where should we go next?. Future Virol. 2013, 8(12):1161-1182.
46. Scobie L., Dalton H.R. Hepatitis E: source and route of infection, clinical manifestations and new developments. J. Viral. Hepat. 2013, 20(1):1-11.
47. Sekijima M., Waki S., Sahara H., Tasaki M., Wilkinson R.A., Villani V., Shimatsu Y., Nakano K., Matsunari H., Nagashima H., Fishman J.A., Shimizu A., Yamada K. Results of life-supporting galactosyltransferase knockout kidneys in cynomolgus monkeys using two different sources of galactosyltransferase knockout swine. Transplantation 2014, 98(4):419-426.
48. Semaan M., Kaulitz D., Petersen B., Niemann H., Denner J. Long-term effects of PERV-specific RNA interference in transgenic pigs. Xenotransplantation 2012, 19(2):112-121.
49. Specke V., Plesker R., Wood J., Coulibaly C., Suling K., Patience C., Kurth R., Schuurman H.J., Denner J. No in vivo infection of triple immunosuppressed non-human primates after inoculation with high titers of porcine endogenous retroviruses. Xenotransplantation 2009, 16(1):34-44.
50. Tacke S.J., Specke V., Denner J. Differences in release and determination of subtype of porcine endogenous retroviruses produced by stimulated normal pig blood cells. Intervirology 2003, 46(1):17-24.
51. Widen B.F., Lowings J.P., Belak S., Banks M. Development of a PCR system for porcine cytomegalovirus detection and determination of the putative partial sequence of its DNA polymerase gene. Epidemiol. Infect. 1999, 123(1):177-180.
52. Wijkstrom M., Bottino R., Cooper D.K.C. Commentary. Limitations of the pig-to-non-human primate islet transplantation model. Xenotransplantation 2013, 20:2-4.
53. Wynyard S., Nathu D., Garkavenko O., Denner J., Elliott R. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation 2014, 21:309-323.
54. Yamada K., Tasaki M., Sekijima M., Wilkinson R.A., Villani V., Moran S.G., Cormack T.A., Hanekamp I.M., Arn J.S., Fishman J.A., Shimizu A., Sachs D.H. Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model. Transplantation 2014, 98:411-418.